| John Mitty Friday, April 5, 2013 |
Eight High School Students Named Finalists in National
Biotechnology Research Competition
Elite Eight Head to Chicago to Compete Against Top Students
From Across the Nation
Washington, D.C. – April 5 ,2013 – The Biotechnology Institute today named eight students across the nation as the winners of the 2013 At-Large BioGENEius Challenge, the premier competition for high school students that recognizes outstanding research in biotechnology. Next up: The Elite Eight will be granted insider access to the biotechnology industry through their attendance at the 2013 BIO International Convention in Chicago, the industry’s trade conference, where leading companies, scientists and innovators will offer students a first-hand experience on what a dynamic career in the industry can encompass.
2013 At-Large BioGENEius Challenge Winners
Michelle Campeau - Rochester, Minnesota
Eric Chen - San Diego, California
Nebiyou Getahun - Jericho, New York
Michelle Guo - Hackensack, New Jersey
Vikul Gupta - Portland, Oregon
Sahir Jaggi - Latham, New York
Rena Weis - New Prague, Minnesota
Sunny Zheng - Plainview, New York
While in Chicago, these students will compete against students from across the country in the U.S. National BioGENEius Challenge. If named a finalist, they will go on to compete against a select number of students from the U.S., Canada and Australia in the International BioGENEius Challenge. Each stage of the competition will take place in Chicago during the2013 BIO International Convention.
The first place winner in the International competition will receive a $7,500 cash prize, the second place winner will receive $5,000, the third place winner will receive $2,500 and the fourth place winner will receive $1,000.
“At a time when the U.S. is struggling to engage students in the sciences, the BioGENEius Challenge has found a way to encourage those students who are excited about biotechnology to reach for the next level,” said Jeffrey Almond, Ph.D., Vice President for Discovery Research at Sanofi Pasteur. “We are thrilled to participate in a program that cultivates young, innovative minds to address our global challenges in new ways.”
“Through the BioGENEius Challenge, students gain an appreciation for the fascinating aspects of scientific experimentation and the tremendous potential for biotechnology to continue to address some of the most pressing issues of our time,” added Jay P. Siegel, M.D., Chief Biotechnology Officer and Head of Global Regulatory Affairs, Janssen Research & Development, LLC. “It is our expectation that this program will draw bright young people into the endeavor of biotechnology and help accelerate the development of the next-generation of scientific leaders.”
The BioGENEius Challenge is organized by the Biotechnology Institute, the national organization dedicated to biotechnology education. Generous Co-Lead Supporters of the Challenge include Sanofi Pasteur, the vaccines division of leading global pharmaceutical company Sanofi, and Janssen Pharmaceutical Companies of Johnson & Johnson.
In addition to Sanofi Pasteur and Janssen, support for the BioGENEius Challenge is provided by International Supporters: The Astellas Foundation, Genentech and MedImmune; and U.S. National Supporters: Acorda Therapeutics, The Allergan Foundation, BioMarin and Sangamo BioSciences.
# # #
About the Biotechnology Institute
The Biotechnology Institute is an independent, national nonprofit organization dedicated to education about the present and future impact of biotechnology. Its mission is to engage, excite and educate the public, particularly students and teachers, about biotechnology and its immense potential for solving human health, food and environmental problems. For more information, visit www.biotechinstitute.org.
About Sanofi Pasteur
Sanofi Pasteur, the vaccines division of Sanofi, provides more than 1 billion doses of vaccine each year, making it possible to immunize more than 500 million people across the globe. A world leader in the vaccine industry, Sanofi Pasteur offers the broadest range of vaccines protecting against 20 infectious diseases. The company's heritage, to create vaccines that protect life, dates back more than a century. Sanofi Pasteur is the largest company entirely dedicated to vaccines. Every day, the company invests more than EUR 1 million in research and development. For more information, please visit: www.sanofipasteur.com or www.sanofipasteur.us
About Janssen
At Janssen Research & Development, LLC, we are dedicated to addressing and solving some of the most important unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, and cardiovascular and metabolic diseases. Driven by our commitment to patients, we develop innovative products, services and healthcare solutions to help people throughout the world. For more information, please visit: www.janssenrnd.com
jmitty@longislandyellowpages.com Appears In: Press Releases
 |
|
||||
The LIYellowPages.com - Your Local Yellow Page Resource - (631) 306-2000 - Email Us | About Us
Categories | Cities | Career Opportunities | Link To Us | Terms of Service | Privacy | Search | Site Map | Advertise
All rights reserved. Copyright © 2016 by Long Island Yellow Pages™ | Publication by Long Island Media, Inc.
